Baxano
Develops minimally-invasive tools to restore spine function and preserve healthy tissues.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD62—93m (Dealroom.co estimates Apr 2014.)
San Jose California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$20.0m | Series B | ||
$30.0m | Series C | ||
$23.6m Valuation: $23.6m | Acquisition | ||
| N/A | $1.2m | Early VC | |
| N/A | $10.0m | Early VC | |
| Total Funding | AUD94.6m | ||
Related Content
Recent News about Baxano
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.